|
1）Alonso A, Sasin J, Bottini N, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004; 117: 699-711
|
|
|
|
2）Pao LI, Badour K, Siminovitch KA, et al. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu Rev Immunol. 2007; 25: 473-523
|
|
|
|
|
|
3）Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002; 2: 309-22
|
|
|
|
|
|
4）Yasutomo K, Doyle C, Miele L, et al. The duration of antigen receptor signaling determines CD4＋ versus CD8＋ T-cell lineage fate. Nature. 2000; 404: 506-10
|
|
|
|
|
|
5）Liu X, Bosselut R. Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol. 2004; 5: 280-8
|
|
|
|
|
|
6）Adachi S, Iwata M. Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes. Cell Immunol. 2002; 215: 45-53
|
|
|
|
|
|
7）Dave VP, Allman D, Keefe R, et al. HD mice: a novel mouse mutant with a specific defect in the generation of CD4＋ T cells. Proc Natl Acad Sci USA. 1998; 95: 8187-92
|
|
|
|
|
|
8）He X, He X, Dave VP, et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature. 2005; 433: 826-33
|
|
|
|
|
|
9）Sun G, Liu X, Mercado P, et al. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol. 2005; 6: 373-81
|
|
|
|
|
|
10）Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002; 111: 621-33
|
|
|
|
|
|
11）Agui T, Oka M, Yamada T, et al. Maturational arrest from CD4＋8＋ to CD4＋8- thymocytes in a mutant strain (LEC) of rat. J Exp Med. 1990; 172: 1615-24
|
|
|
|
|
|
12）Sakai T, Agui T, Matsumoto K. Expression of major histocompatibility complex class II but not of CD8 molecules by lectin-stimulated peripheral CD4＋ T cells in LEC mutant rats. Cell Immunol. 1994; 158: 414-22
|
|
|
|
|
|
13）Wei K, Muramatsu Y, Sakai T, et al. Chromosomal mapping of the T-helper immunodeficiency (thid) locus in LEC rats. Immunogenetics. 1997; 47: 99-102
|
|
|
|
|
|
14）Kose H, Sakai T, Tsukumo S, et al. Maturational arrest of thymocyte development is caused by a deletion in the receptor-like protein tyrosine phosphatase kappa gene in LEC rats. Genomics. 2007; 89: 673-7
|
|
|
|
|
|
15）Anders L, Mertins P, Lammich S, et al. Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity. Mol Cell Biol. 2006; 26: 3917-34
|
|
|
|
|
|
16）Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003; 21: 107-37
|
|
|
|
|
|
17）Byth KF, Conroy LA, Howlett S, et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4＋CD8＋ thymocytes, and B cell maturation. J Exp Med. 1996; 183: 1707-18
|
|
|
|
|
|
18）Majeti R, Xu Z, Parslow TG, et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 2000; 103: 1059-70
|
|
|
|
|
|
19）Tchilian EZ, Beverley PCL. Altered CD45 expression and disease. Trends Immunol. 2006; 27: 146-53
|
|
|
|
|
|
20）Van Vliet SJ, Gringhuis SI, Geijtenbeek TBH, et al. Regunation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol. 2006; 7: 1200-8
|
|
|
|
|
|
21）Heyd F, ten Dam G, Moroy T. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooerate directly in regulating CD45 alternative splicing. Nat Immunol. 2006; 7: 859-67
|
|
|
|
|
|
22）Huntington ND, Xu T, Puthalakath H, et al. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat Immunol. 2006; 7: 190-8
|
|
|
|
|
|
23）Maksumova L, Le HT, Muratkhodjaev F, et al. Protein tyrosine phosphatase a regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts. J Immunol. 2005; 175: 7947-56
|
|
|
|
|
|
24）Borges LG, Seifert RA, Grant FJ, et al. Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells. Circ Res. 1996; 79: 570-80
|
|
|
|
|
|
25）Kuramochi S, Matsuda S, Matsuda Y, et al. Molecular cloning and characterization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP-1. FEBS Lett. 1996; 378: 7-14
|
|
|
|
|
|
26）Honda H, Inazawa J, Nishida J, et al. Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta. Blood. 1994; 84: 7186-94
|
|
|
|
|
|
27）Ostman A, Yang Q, Tonks NK. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA. 1994; 91: 9680-4
|
|
|
|
|
|
28）Jiang G, den Hertog J, Hunter T. Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol Cell Biol. 2000; 20: 5917-29
|
|
|
|
|
|
29）Keane MM, Lowrey GA, Ettenberg SA, et al. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 1996; 56: 4236-43
|
|
|
|
|
|
30）Trapasso F, Iuliano R, Boccia A, et al. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27Kip1. Mol Cell Biol. 2000; 20: 9236-46
|
|
|
|
|
|
31）Takahashi T, Takahashi K, St John PL, et al. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol. 2003; 23: 1817-31
|
|
|
|
|
|
32）Baker JE, Majeti R, Tangye SG, et al. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation. Mol Cell Biol. 2001; 21: 2393-403
|
|
|
|
|
|
33）Lin J, Weiss A. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. J Cell Biol. 2003; 162: 673-82
|
|
|
|
|
|
34）Lin J, Zhu JW, Baker JE, et al. Regulated expression of the receptor-like tyrosine phosphatase CD148 on hemopoietic cells. J Immunol. 2004; 173: 2324-30
|
|
|
|
|